Picture of Novakand Pharma AB logo

NOVKAN — Novakand Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Kancera Provides Operational Update In Connection With Q2 Interim Report Release

Aug 18 (Reuters) - Kancera AB  KANC.ST :
    * KANCERA PROVIDES OPERATIONAL UPDATE IN CONNECTION WITH
RELEASE
OF FINANCIAL INTERIM REPORT FOR SECOND QUARTER
    * TOP LINE RESULTS FROM ONGOING FRACTAL STUDY ARE EXPECTED
TO BE
PRESENTED DURING Q4 OF THIS YEAR
    * REVIEW OF KANCERA'S REGULATORY APPLICATION TO CONDUCT A
PHASE I
STUDY OF KAND145 IS STILL ONGOING

Source text for Eikon:  ID:nMFN8r0J9M 
Further company coverage:  KANC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))

Recent news on Novakand Pharma AB

See all news